Arcutis Biotherapeutics, Inc.
Total Trades
200
Buys
12
Sells
137
Largest Trade
N/A
Insiders
21
Institutional Funds
225
Inst. Value
$1M+
Activist Filings
37
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Matsuda Masaru | See Remark | GRANT | N/A | 5K | — | May 29, 2024 |
| Moore Matthew Richard | SVP and Chief Busi… | SELL | $15K–$50K | 5K | $8.74 | May 3, 2024 |
| Moore Matthew Richard | SVP and Chief Busi… | GRANT | N/A | 4K | — | May 3, 2024 |
| Watanabe Todd Franklin | See Remarks | SELL | $100K–$500K | 14K | $8.74 | May 3, 2024 |
| Matsuda Masaru | See Remark | SELL | $15K–$50K | 5K | $8.74 | May 3, 2024 |
| Burnett Patrick | See Remarks | SELL | $50K–$100K | 10K | $8.74 | May 3, 2024 |
| Watanabe Todd Franklin | See Remarks | SELL | $15K–$50K | 2K | $10.60 | Mar 1, 2024 |
| Burnett Patrick | See Remarks | SELL | $1K–$15K | 1K | $3.54 | Jan 3, 2024 |
| Watanabe Todd Franklin | See Remarks | BUY | $1K–$15K | 1K | $6.38 | Dec 2, 2023 |
| Watanabe Todd Franklin | See Remarks | EXERCISE | $100K–$500K | 60K | $1.68 | Dec 2, 2023 |
| Matsuda Masaru | See Remark | GRANT | N/A | 5K | — | Nov 21, 2023 |
| Matsuda Masaru | See Remark | SELL | $1K–$15K | 2K | $1.98 | Nov 21, 2023 |
| Frazier Life Sciences VIII, L.P. | 10% Owner | BUY | $100K–$500K | 80K | $2.50 | Oct 26, 2023 |
| Burnett Patrick | See Remarks | SELL | $1K–$15K | 2K | $7.04 | Aug 22, 2023 |
| Matsuda Masaru | See Remark | SELL | $1K–$15K | 2K | $7.80 | Jun 3, 2023 |
| Matsuda Masaru | See Remark | GRANT | $1K–$15K | 6K | $1.47 | Jun 3, 2023 |
| Welgus Howard G. | Director | EXERCISE | $1K–$15K | 9K | $1.68 | Apr 18, 2023 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 9K | $13.97 | Apr 18, 2023 |
| Welgus Howard G. | Director | EXERCISE | $1K–$15K | 9K | $1.68 | Apr 10, 2023 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 9K | $12.01 | Apr 10, 2023 |
| Watanabe Todd Franklin | See Remarks | SELL | $15K–$50K | 2K | $15.26 | Mar 8, 2023 |
| Burrows Scott L | CFO | SELL | $1K–$15K | 291 | $15.26 | Mar 8, 2023 |
| Burnett Patrick | See Remarks | SELL | $1K–$15K | 851 | $15.26 | Mar 8, 2023 |
| Turney Patricia A. | SVP, Operations | SELL | $1K–$15K | 831 | $15.26 | Mar 8, 2023 |
| OSBORNE DAVID W | Chief Technical Of… | SELL | $1K–$15K | 690 | $15.26 | Mar 8, 2023 |
| Lock Kenneth A. | Chief Commercial O… | SELL | $1K–$15K | 831 | $15.26 | Mar 8, 2023 |
| Moore Matthew Richard | See Remarks | GRANT | N/A | 15K | — | Mar 6, 2023 |
| Moore Matthew Richard | See Remarks | SELL | $15K–$50K | 2K | $15.83 | Mar 6, 2023 |
| Matsuda Masaru | See Remarks | GRANT | N/A | 21K | — | Mar 6, 2023 |
| Matsuda Masaru | See Remarks | SELL | $15K–$50K | 1K | $15.83 | Mar 6, 2023 |
| Burnett Patrick | See Remarks | SELL | $15K–$50K | 2K | $15.83 | Mar 6, 2023 |
| Burnett Patrick | See Remarks | GRANT | N/A | 21K | — | Mar 6, 2023 |
| Turney Patricia A. | SVP, Operations | SELL | $15K–$50K | 2K | $15.96 | Mar 3, 2023 |
| Watanabe Todd Franklin | See Remarks | SELL | $100K–$500K | 8K | $15.93 | Mar 3, 2023 |
| Burrows Scott L | CFO | SELL | $15K–$50K | 2K | $15.90 | Mar 3, 2023 |
| Lock Kenneth A. | Chief Commercial O… | SELL | $15K–$50K | 2K | $15.96 | Mar 3, 2023 |
| OSBORNE DAVID W | Chief Technical Of… | SELL | $15K–$50K | 2K | $15.96 | Mar 3, 2023 |
| Welgus Howard G. | Director | EXERCISE | $1K–$15K | 9K | $1.68 | Feb 21, 2023 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 9K | $16.98 | Feb 21, 2023 |
| Watanabe Todd Franklin | See Remarks | SELL | $15K–$50K | 1K | $17.01 | Feb 16, 2023 |
| Watanabe Todd Franklin | See Remarks | SELL | $15K–$50K | 1K | $17.00 | Feb 3, 2023 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 9K | $13.72 | Jan 19, 2023 |
| Welgus Howard G. | Director | EXERCISE | $1K–$15K | 9K | $1.68 | Jan 19, 2023 |
| Burnett Patrick | See Remarks | SELL | $15K–$50K | 1K | $15.01 | Jan 4, 2023 |
| Watanabe Todd Franklin | See Remarks | SELL | $15K–$50K | 1K | $17.06 | Dec 9, 2022 |
| Matsuda Masaru | See Remark | SELL | $15K–$50K | 2K | $18.19 | Nov 23, 2022 |
| Matsuda Masaru | See Remark | GRANT | N/A | 5K | — | Nov 23, 2022 |
| Welgus Howard G. | Director | EXERCISE | $1K–$15K | 1K | $1.68 | Nov 17, 2022 |
| Welgus Howard G. | Director | SELL | $50K–$100K | 3K | $20.01 | Nov 17, 2022 |
| Watanabe Todd Franklin | See Remarks | SELL | $15K–$50K | 1K | $18.00 | Nov 9, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 225 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9.9M | $1M+ | SH |
| Rubric Capital Management LP | 8.3M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 5.6M | $1M+ | SH |
| STATE STREET CORP | 5.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $1M+ | SH |
| Ensign Peak Advisors, Inc | 1.9M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.5M | $1M+ | SH |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.4M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.0M | $1M+ | SH |
| GW&K Investment Management, LLC | 939K | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 914K | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 900K | $1M+ | SH |
| Perpetual Ltd | 824K | $1M+ | SH |
| Candriam S.C.A. | 803K | $1M+ | SH |
| VANGUARD GROUP INC | 763K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 700K | $1M+ | SH |
| FISHMAN JAY A LTD/MI | 565K | $1M+ | SH |
| MPM BioImpact LLC | 531K | $1M+ | SH |
| Cormorant Asset Management, LP | 500K | $1M+ | SH |
| Capitolis Liquid Global Markets LLC | 500K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
6.8%
8.3M shares
SC 13G/A · Feb 13, 2026
5.7%
7.1M shares
SC 13G/A · Jan 30, 2026
5.5%
6.8M shares
SC 13G/A · Oct 6, 2025
10.2%
12.3M shares
Frazier Life Sciences VIII, L.P.
SC 13D/A · Aug 20, 2025
7.3%
8.8M shares
SC 13G/A · Aug 14, 2025
4.2%
5.0M shares
SC 13G/A · May 15, 2025
10.1%
12.0M shares
SC 13G/A · May 15, 2025
5.7%
6.7M shares
SC 13G/A · May 8, 2025
9.6%
11.4M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
0.2%
247K shares
SC 13G/A · Nov 13, 2024
9.4%
11.0M shares
SC 13G/A · Nov 8, 2024
7.7%
9.0M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G/A · Nov 6, 2024
3.4%
4.0M shares
SC 13G/A · Oct 22, 2024
7.7%
9.0M shares
Frazier Life Sciences VIII, L.P. 2.
SC 13D/A · Mar 6, 2024
7.8%
8.8M shares
Jennison Associates LLC IRS Identification #52-2069785 (formerly 13-2631108)
SC 13G/A · Mar 6, 2024
10.8%
12.1M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.2%
4.9M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2024
10.0%
9.5M shares
SC 13G/A · Feb 13, 2024
6.7%
6.3M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G · Feb 12, 2024
6.5%
6.1M shares
SC 13G · Feb 12, 2024
7.0%
6.6M shares
Point72 Asset Management, L.P.
SC 13G · Jan 31, 2024
5.1%
4.8M shares
SC 13G · Jan 29, 2024
6.3%
5.9M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
1.6%
0 shares
SC 13G · Nov 16, 2023
7.6%
7.1M shares
SC 13G/A · Nov 13, 2023
3.8%
3.6M shares
SC 13G/A · Nov 7, 2023
4.1%
3.9M shares
Suvretta Capital Management, LLC
SC 13G · Oct 30, 2023
10.0%
9.6M shares
Frazier Life Sciences VIII, L.P. 2.
SC 13D/A · Oct 26, 2023
9.3%
8.8M shares
SC 13G/A · Feb 3, 2023
8.6%
5.2M shares
SC 13D/A · Aug 26, 2022
4.7%
2.8M shares
Frazier Life Sciences VIII, L.P.
SC 13D/A · Aug 9, 2022
14.5%
8.7M shares
Bain Capital Life Sciences Fund, L.P.
SC 13D/A · Aug 8, 2022
4.5%
2.7M shares
SC 13D/A · Aug 8, 2022
5.4%
3.1M shares
SC 13D/A · Jun 28, 2022
6.9%
3.5M shares
Bain Capital Life Sciences Fund, L.P.
SC 13D/A · May 27, 2022
5.3%
2.7M shares
SC 13D/A · Apr 8, 2022
7.6%
3.8M shares